tiprankstipranks
Trending News
More News >
pc:syn6e

Synthesize Bio

Synthesize Bio is a biotechnology company at the forefront of generative genomics, utilizing AI-driven models to simulate gene expression experiments. Their flagship product, Generate Expression Model-1 (GEM-1), is built on an extensive RNA-seq dataset and enables the generation of gene expression data from experimental designs, facilitating drug discovery and scientific research. Founded by scientists from Fred Hutchinson Cancer Center, Synthesize Bio aims to transform biopharmaceutical innovation by providing high-fidelity predictive models that enhance laboratory results and accelerate the development of new therapies.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$10M
Total Amount Raised$10M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$10M
Latest Funding Amount$10M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 17, 2025
Seed Round
$10.00M

Investors

Investor Name
Funding Round
Seed Round
Seed Round
Seed Round

Related News and Analysis